These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14727847)

  • 1. Scale-up effects on dissolution and bioavailability of propranolol hydrochloride and metoprolol tartrate tablet formulations.
    Eddington ND; Rekhi GS; Lesko LJ; Augsburger LL
    AAPS PharmSciTech; 2000 Jun; 1(2):E14. PubMed ID: 14727847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations.
    Rekhi GS; Eddington ND; Fossler MJ; Schwartz P; Lesko LJ; Augsburger LL
    Pharm Dev Technol; 1997 Feb; 2(1):11-24. PubMed ID: 9552427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of food on the relative bioavailability of rapidly dissolving immediate-release solid oral products containing highly soluble drugs.
    Yu LX; Straughn AB; Faustino PJ; Yang Y; Parekh A; Ciavarella AB; Asafu-Adjaye E; Mehta MU; Conner DP; Lesko LJ; Hussain AS
    Mol Pharm; 2004; 1(5):357-62. PubMed ID: 16026005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and internal validation of an in vitro-in vivo correlation for a hydrophilic metoprolol tartrate extended release tablet formulation.
    Eddington ND; Marroum P; Uppoor R; Hussain A; Augsburger L
    Pharm Res; 1998 Mar; 15(3):466-73. PubMed ID: 9563079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of "external" predictability of an in vitro-in vivo correlation for an extended-release formulation containing metoprolol tartrate.
    Mahayni H; Rekhi GS; Uppoor RS; Marroum P; Hussain AS; Augsburger LL; Eddington ND
    J Pharm Sci; 2000 Oct; 89(10):1354-61. PubMed ID: 10980510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability studies of expired tablets of metoprolol tartrate and propranolol hydrochloride. Part 2. Dissolution study.
    Jasińska M; Karwowski B; Orszulak-Michalak D; Kurczewska U
    Acta Pol Pharm; 2009; 66(6):703-7. PubMed ID: 20050535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of stereoselective pharmacokinetics in the development and predictability of an IVIVC for the enantiomers of metoprolol tartrate.
    Sirisuth N; Eddington ND
    Pharm Res; 2000 Aug; 17(8):1019-25. PubMed ID: 11028951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
    Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C
    Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tablets.
    Eddington ND; Ashraf M; Augsburger LL; Leslie JL; Fossler MJ; Lesko LJ; Shah VP; Rekhi GS
    Pharm Dev Technol; 1998 Nov; 3(4):535-47. PubMed ID: 9834957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers.
    Deroubaix X; Lins RL; Lens S; Demblon C; Jeanbaptiste B; Poelaert D; Stockis A
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):61-70. PubMed ID: 8929748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.
    Kim JE; Ki MH; Yoon IS; Cho HJ; Kim RS; Tae Kim G; Kim DD
    Clin Ther; 2014 Feb; 36(2):273-9. PubMed ID: 24529292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
    Gordon MS; Chowhan Z
    Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of In Vitro-In Vivo Correlation for Amorphous Solid Dispersion Immediate-Release Suvorexant Tablets and Application to Clinically Relevant Dissolution Specifications and In-Process Controls.
    Kesisoglou F; Hermans A; Neu C; Yee KL; Palcza J; Miller J
    J Pharm Sci; 2015 Sep; 104(9):2913-22. PubMed ID: 25611455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dependence of in vitro-in vivo correlation analysis acceptability on model selections.
    Polli JE
    Pharm Dev Technol; 1999 Jan; 4(1):89-96. PubMed ID: 10027217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence of two enteric coated formulations of pantoprazole in healthy volunteers under fasting and fed conditions.
    de Campos DR; Vieira NR; Bernasconi G; Barros FA; Meurer EC; Marchioretto MA; Coelho EC; Calafatti SA; Sommer C; Couto JM; Buranello S; Silva AR; Amarante AR; Abib E; Júnior JP
    Arzneimittelforschung; 2007; 57(6):309-14. PubMed ID: 17688075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic evaluation of guar gum-based three-layer matrix tablets for oral controlled delivery of highly soluble metoprolol tartrate as a model drug.
    Al-Saidan SM; Krishnaiah YS; Satyanarayana V; Bhaskar P; Karthikeyan RS
    Eur J Pharm Biopharm; 2004 Nov; 58(3):697-703. PubMed ID: 15451547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of USP apparatus 3 for dissolution testing of immediate-release products.
    Yu LX; Wang JT; Hussain AS
    AAPS PharmSci; 2002; 4(1):E1. PubMed ID: 12049485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of critical formulation and processing variables for metoprolol tartrate extended-release (ER) matrix tablets.
    Rekhi GS; Nellore RV; Hussain AS; Tillman LG; Malinowski HJ; Augsburger LL
    J Control Release; 1999 Jun; 59(3):327-42. PubMed ID: 10332064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermal sintering: a novel technique used in the design, optimization and biopharmaceutical evaluation of propranolol HCl gastric floating tablets.
    Venkata Srikanth M; Songa AS; Nali SR; Battu JR; Kolapalli VR
    Drug Dev Ind Pharm; 2014 Jan; 40(1):33-45. PubMed ID: 23317339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.